Burkholderia cepacia Complex Infection in a Cohort of Italian Patients with Cystic Fibrosis |
Lambiase, Antonietta
(Department of Biology and Pathology Cellular and Molecular "Luigi Califano")
Raia, Valeria (Department of Pediatrics, Regional Cystic Fibrosis Center, University of Naples "Federico II") Stefani, Stefania (Department of Microbiological and Gynecological Sciences, University of Catania) Sepe, Angela (Department of Pediatrics, Regional Cystic Fibrosis Center, University of Naples "Federico II") Ferri, Pasqualina (Department of Pediatrics, Regional Cystic Fibrosis Center, University of Naples "Federico II") Buonpensiero, Paolo (Department of Pediatrics, Regional Cystic Fibrosis Center, University of Naples "Federico II") Rossano, Fabio (Department of Biology and Pathology Cellular and Molecular "Luigi Califano") Pezzo, Mariassunta Del (Department of Biology and Pathology Cellular and Molecular "Luigi Califano") |
1 | Coenye, T., P. Vandamme, J.R.W. Govan, and J.J. LiPuma. 2001. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 39, 3427-3436 DOI ScienceOn |
2 | Gilligan, P.H. 1991. Microbiology of airway disease in patients with Cystic Fibrosis. Clin. Microbiol. Rev. 4, 35-51 DOI PUBMED |
3 | Goldstein, R., L. Sun, R.Z. Jiang, U. Sajjan, J. Forstner, and C. Campanelli. 1995. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J. Bacteriol. 177, 1039-1052 DOI PUBMED |
4 | Saiman, L, N. MacDonald, J.L. Burns, N. Hoiby, D.P. Speert, and D. Weber. 2000. Infection control in cystic fibrosis: practical recommendations for the hospital, clinic, and social setting. Am. J. Infect. Control. 28, 381-385 DOI ScienceOn |
5 | Saiman, L., N.E. MacDonald, and S. Whittier. 1996. The microbiological basis for antimicrobial therapy. In Tenth Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation. Orlando, USA |
6 | Sun, L., R. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, Y. Tan, M. Riley, and R. Goldstein. 1995. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing Cystic Fibrosis centre epidemics in North America and Britan. Nat. Med. 1, 661-666 DOI |
7 | Tablan, O.C., T.L. Chorba, D.V. Schidlow, J.W. White, K.A. Hardy, P.H. Gilligan, W.M. Morgan, L.A. Carson, W.J. Martone, J.M. Jason, and W.R. Jarvis. 1985. Pseudomonas cepacia colonization in patients with Cystic Fibrosis: risk factors and clinical outcome. J. Pediatr. 107, 382-387 DOI |
8 | McDowell, A., E. Mahenthiralingam, J.E. Moore, K.E.A. Dunbar, A.K. Webb, M.E. Dodd, S.L. Martin, B.C. Millar, C.J. Scott, M. Crowe, and J.S. Elborn. 2001. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J. Clin. Microbiol. 39, 4247-4255 DOI ScienceOn |
9 | Sajjan, U., L. Sun, R. Goldstein, and J. Forstner. 1995. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177, 1030-1038 DOI PUBMED |
10 | Mahenthiralingam, E. and P. Vandamme. 2005. Taxonomy and pathogenesis of the Burkholderia cepacia complex. Chron. Respir. Dis. 2, 209-217 DOI |
11 | Lipuma, J.J. 2005. Update on the Burkholderia cepacia complex. Curr. Opin. Pulm. Med. 11, 528-533 DOI ScienceOn |
12 | Saiman, L. and J. Siegel. 2003. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens and infection control practices to prevent patient-to-patient transmission. Am. J. Infect. Control. 3 (Suppl) |
13 | Agodi, A., E. Mahenthiralingam, M. Barchitta, V. Giannino, A. Sciacca, and S. Stefani. 2001. Burkholderia cepacia complex in fection in italian patients with cystic fibrosis: prevalence, epidemiology and genomovar status. J. Clin. Microbiol. 39, 2891-2896 DOI ScienceOn |
14 | Vermis, K., T. Coenye, J.J. LiPuma, E. Mahentheralingam, H.J. Nelis, and P. Vandamme. 2004. Proposal to accomodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int. J. Syst. Evol. Microbiol. 54, 689-691 DOI ScienceOn |
15 | Manno, G., C. Dalmastri, S. Tabacchioni, P. Vandamme, R. Lorini, L. Minicicci, L. Romano, A. Giannattasio, L. Chiarini, and A. Bevivino. 2004. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center. J. Clin. Microbiol. 42, 1491-1497 DOI |
16 | Tenover, F., R. Arbeit, R. Goering, P. Mickelsen, B. Murray, D. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233-2239 PUBMED |
17 | Frederiksen, B., C. Koch, and N. Hoiby. 1999. Changing epidemiology of Pseudomonas aeruginosa infection in Danish Cystic Fibrosis patients (1974-1995). Pediatr Pulmonol. 28, 159-166 DOI ScienceOn |
18 | Mahenthiralingam, E., D. Simpson, and D.P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35, 808-816 PUBMED |
19 | Grothues, D., U. Koopmann, H. Van der Hardt, and B. Tummler. 1988. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J. Clin. Microbiol. 26, 115-123 |
20 | LiPuma, J.J., T. Spilker, L.H. Gill, P.W. Campbell, L. Liu, and E. Mahenthiralingam. 2001. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 164, 92-99 DOI PUBMED ScienceOn |
21 | Mahenthiralingam, E., J. Bischof, S.K. Byrne, C. Radomski, J.E. Davies, Y. Av-Gay, and P. Vandamme. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38, 3165-3173 PUBMED |
22 | LiPuma, J.J. 1998. Burkholderia cepacia. Management issues and new insights. Clin. Chest Med. 19, 473-486 DOI |
23 | Vandamme, P., D. Henry, T. Coenye, S. Nuzla, M. Vancanneyt, J.J. LiPuma, D.P. Speert, J.R.W. Govan, and E. Mahenthiralingam. 2002. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol. Med. Microbiol. 33, 143-149 DOI |
24 | National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa, USA |
25 | Cystic Fibrosis Foundation. 2003. Patient Registry: Annual Data Report. Bethesda |
26 | Lambiase, A., V. Raia, M. Del Pezzo, A. Sepe, V. Carnovale, and F. Rossano. 2006. Microbiology airway disease in a cohort of patients with cystic fibrosis. BMC Infect. Dis. 6, 4 DOI ScienceOn |
27 | Allice, T., S. Scutera, M.G. Chirillo, and D. Savoia. 2006. Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization. J. Infect. 53, 159-165 DOI ScienceOn |